On October 11, 2016, Merck Sharp & Dohme (MSD) filed for IPR on U.S. Patent No. 6,331,415, one of the Cabilly patents owned by Genentech. IPR2017-00047. MSD also filed a motion for joinder with Mylan’s petition for IPR on this patent (IPR2016-00710), representing that its petition is based on grounds identical to those that form the basis for Mylan’s IPR. MSD’s petition and other important IPR documents on biologic patents are posted on our IPR tracker page.
Blog Big Molecule Watch October 13, 2016